Joanna Sexter
Pediatrics · Washington, DCNPI 1568514123
Payments from drug & device makers
What this record shows
22 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 54.9% of the total. Reporting peaked in 2024 at $2,250 and has fallen 85.9% since, to $317 in 2025. Among pediatrics clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $39.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$2K
- Merck$313
- Pfizer$287
- Cranial Technologies, Inc$259
- Supernus Pharmaceuticals, Inc.$210
- Kaleo, Inc.$135
- plus $527 from 16 others
Across 101 payments — averaging $29,849 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$2.8M
- Novavax Inc$154K
- GSK$53K
- Bausch Health US, LLC$14K
- Biohaven Pharmaceutical Holding Company Ltd.$9K
What the payments were for
- Consulting fees$1,70044%
- Food & beverage$2,13556%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 8 | $2,104 |
| Merck | 14 | $313 |
| Pfizer | 14 | $287 |
| Cranial Technologies, Inc | 19 | $259 |
| Supernus Pharmaceuticals, Inc. | 10 | $210 |
| Kaleo, Inc. | 6 | $135 |
| GSK | 3 | $58 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $57 |
| Sanofi Pasteur Inc. | 3 | $54 |
| Genentech USA, Inc. | 2 | $47 |
| AstraZeneca | 2 | $43 |
| Verrica Pharmaceuticals Inc. | 2 | $38 |
| Adlon Therapeutics L.p. | 2 | $37 |
| Meridian Bioscience Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| Dermira, Inc. | 1 | $19 |
| Seqirus USA Inc | 1 | $19 |
| Sobi, Inc | 1 | $19 |
| Phadia US Inc. | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$139
How this compares
$3,835 in reported general payments places this provider in the 90th percentile of 288 pediatrics providers in District of Columbia.
Other pediatrics in Washington
- Helen ThackrayWashington$4.6M
- Brenda MartinWashington$156K
- David NelsonWashington$71K
- Christina GrantWashington$56K
- Ariel LevyWashington$49K
- Maia McCuistonWashington$23K
- Craig SableWashington$22K
- Caroline van VleckWashington$18K
- Barbara Speller BrownWashington$16K
- Hemant SharmaWashington$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.